SCHEMBL1997120

SCHEMBL1997120

CCOC(=O)Cc1c(C)nn(-c2ccc(-c3ccccc3)cc2)c1-c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
KDM4E B2RXH2 5/20 0.53
HSD17B10 Q99714 3/20 0.53
TSHR P16473 3/20 0.53
L3MBTL1 Q9Y468 4/20 0.50
CYP2C9 P11712 3/20 0.50
CYP2C19 P33261 3/20 0.50
NPSR1 Q6W5P4 2/20 0.50
CYP1A2 P05177 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
CYP3A4 P08684 2/20 0.49
USP2 O75604 1/20 0.48
MAPK1 P28482 1/20 0.48
HPGD P15428 4/20 0.47
HTT P42858 3/20 0.47
GAA P10253 1/20 0.47
PDE4D Q08499 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11247967 0.86 CYP2C9 (0.56) ALDH1A1TSHRCYP2C9CYP2C19CYP1A2
SCHEMBL4158179 0.85 MEN1 (0.50) ALDH1A1KDM4EHSD17B10TSHRL3MBTL1
SCHEMBL11240588 0.83 KDM4E (0.50) ALDH1A1KDM4EHSD17B10TSHRL3MBTL1
SCHEMBL6123566 0.83 ALDH1A1 (0.61) ALDH1A1KDM4EHSD17B10TSHRL3MBTL1
SCHEMBL11248894 0.82 ALDH1A1 (0.54) ALDH1A1KDM4EHSD17B10TSHRL3MBTL1
SCHEMBL11243796 0.81 PDE4D (0.63) ALDH1A1KDM4EHSD17B10TSHRL3MBTL1
SCHEMBL1195159 0.80 CYP2C9 (0.62) ALDH1A1TSHRCYP2C9CYP2C19CYP1A2
SCHEMBL11245609 0.80 ALDH1A1 (0.48) ALDH1A1KDM4EHSD17B10TSHRL3MBTL1
SCHEMBL11242309 0.79 SLC2A2 (0.51) ALDH1A1KDM4EHSD17B10TSHRL3MBTL1
SCHEMBL11242627 0.78 CYP1A2 (0.52) ALDH1A1KDM4ECYP2C9CYP2C19NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960413-B2 Pyrazole compounds MERCK PATENT GMBH (DE) 2011-06-14 US disclosed
EP-1611094-B1 PYRAZOLE COMPOUNDS MERCK PATENT GMBH (DE) 2007-06-20 EP disclosed
US-20060276650-A1 Pyrazole compounds MERCK PATENT GMBH (DE) 2006-12-07 US disclosed
EP-1611094-A1 PYRAZOLE COMPOUNDS MERCK PATENT GmbH (DE) 2006-01-04 EP disclosed
WO-2004089888-A1 PYRAZOLE COMPOUNDS MERCK PATENT GMBH (DE) 2004-10-21 WO disclosed
US-4325962-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIDYRETICS BYK-GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1982-04-20 US disclosed
US-4146721-A ANALGESICS, ANTIINFLAMMATORY AGENTS AND ANTIPYRETICS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1979-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276650-A1 Pyrazole compounds HTR1D, HTR1A, HTR3A ALDH1A1 1220/4885KDM4E 3986/4885HSD17B10 3259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.